GO pathway enrichment of gene products differentially regulated by lovastatin exposure as determined by mRNA microarray analysis in 2 or more cell lines
GO . | Enrichment* . | Term . | |||
---|---|---|---|---|---|
Sensitive . | Insensitive† . | ||||
H929 . | KMS11 . | LP1† . | SKMM1† . | ||
GO:0006066 | 1.0 | 2.8 | 4.8 | 6.1 | Alcohol metabolic process |
GO:0009058 | 1.2 | 1.2 | 2.3 | 2.8 | Biosynthetic process |
GO:0003824 | 1.1† | 1.1 | 1.4 | 1.4 | Catalytic activity |
GO:0044255 | 0.8 | 1.5 | 3.3 | 4.9 | Cellular lipid metabolic process |
GO:0006695 | 0.4 | 20.5 | 25.2 | 40.8 | Cholesterol biosynthetic process |
GO:0008203 | 0.7 | 6.6 | 11.0 | 16.6 | Cholesterol metabolic process |
GO:0005737 | 1.2† | 1.4 | 1.3 | 1.4 | Cytoplasm |
GO:0044444 | 1.1 | 1.8 | 1.5 | 1.8 | Cytoplasmic part |
GO:0012505 | 1.0 | 1.8 | 2.0 | 2.6 | Endomembrane system |
GO:0005789 | 0.9 | 3.2 | 2.8 | 4.3 | Endoplasmic reticulum membrane |
GO:0044432 | 0.9 | 2.8 | 2.6 | 3.8 | Endoplasmic reticulum part |
GO:0008299 | 0.7 | 17.1 | 30.5 | 43.2 | Isoprenoid biosynthetic process |
GO:0006720 | 0.4 | 10.2 | 18.3 | 25.9 | Isoprenoid metabolic process |
GO:0008610 | 1.0 | 3.1 | 5.6 | 8.3 | Lipid biosynthetic process |
GO:0006629 | 0.8 | 1.2 | 3.0 | 4.3 | Lipid metabolic process |
GO:0042175 | 0.9 | 3.1 | 2.9 | 4.2 | Nuclear envelope-ER network |
GO:0031090 | 1.0 | 1.7 | 1.7 | 2.5 | Organelle membrane |
GO:0016491 | 0.7 | 3.0 | 2.4 | 2.9 | Oxidoreductase activity |
GO:0006694 | 0.4 | 10.7 | 12.7 | 20.6 | Steroid biosynthetic process |
GO:0008202 | 0.6 | 4.7 | 7.3 | 11.2 | Steroid metabolic process |
GO:0016126 | 0.3 | 24.0† | 25.0 | 40.5 | Sterol biosynthetic process |
GO:0016125 | 0.6 | 9.1 | 12.3 | 18.8 | Sterol metabolic process |
GO . | Enrichment* . | Term . | |||
---|---|---|---|---|---|
Sensitive . | Insensitive† . | ||||
H929 . | KMS11 . | LP1† . | SKMM1† . | ||
GO:0006066 | 1.0 | 2.8 | 4.8 | 6.1 | Alcohol metabolic process |
GO:0009058 | 1.2 | 1.2 | 2.3 | 2.8 | Biosynthetic process |
GO:0003824 | 1.1† | 1.1 | 1.4 | 1.4 | Catalytic activity |
GO:0044255 | 0.8 | 1.5 | 3.3 | 4.9 | Cellular lipid metabolic process |
GO:0006695 | 0.4 | 20.5 | 25.2 | 40.8 | Cholesterol biosynthetic process |
GO:0008203 | 0.7 | 6.6 | 11.0 | 16.6 | Cholesterol metabolic process |
GO:0005737 | 1.2† | 1.4 | 1.3 | 1.4 | Cytoplasm |
GO:0044444 | 1.1 | 1.8 | 1.5 | 1.8 | Cytoplasmic part |
GO:0012505 | 1.0 | 1.8 | 2.0 | 2.6 | Endomembrane system |
GO:0005789 | 0.9 | 3.2 | 2.8 | 4.3 | Endoplasmic reticulum membrane |
GO:0044432 | 0.9 | 2.8 | 2.6 | 3.8 | Endoplasmic reticulum part |
GO:0008299 | 0.7 | 17.1 | 30.5 | 43.2 | Isoprenoid biosynthetic process |
GO:0006720 | 0.4 | 10.2 | 18.3 | 25.9 | Isoprenoid metabolic process |
GO:0008610 | 1.0 | 3.1 | 5.6 | 8.3 | Lipid biosynthetic process |
GO:0006629 | 0.8 | 1.2 | 3.0 | 4.3 | Lipid metabolic process |
GO:0042175 | 0.9 | 3.1 | 2.9 | 4.2 | Nuclear envelope-ER network |
GO:0031090 | 1.0 | 1.7 | 1.7 | 2.5 | Organelle membrane |
GO:0016491 | 0.7 | 3.0 | 2.4 | 2.9 | Oxidoreductase activity |
GO:0006694 | 0.4 | 10.7 | 12.7 | 20.6 | Steroid biosynthetic process |
GO:0008202 | 0.6 | 4.7 | 7.3 | 11.2 | Steroid metabolic process |
GO:0016126 | 0.3 | 24.0† | 25.0 | 40.5 | Sterol biosynthetic process |
GO:0016125 | 0.6 | 9.1 | 12.3 | 18.8 | Sterol metabolic process |